KJIM :: Korean Journal of Internal Medicine

Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics

Yi-an Zhang, Xue Yang, Jiamei Yao, Yuhong Ren, Peng Liu, Naoshad Muhammad

CXCR4 mutations in lymphoplasmacytic lymphoma lead to altered CXCR4 expression

Laura S. Hiemcke‐Jiwa, Roos J. Leguit, N. Mehdi Jiwa, Manon M. H. Huibers, Monique C. Minnema

British Journal of Haematology.2019; 185(5): 966. CrossRef

Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels

Weijie Zhong, Zhigang Zhu, Xin Xu, Hui Zhang, Huabao Xiong, Qingshan Li, Yaming Wei

Journal of Experimental & Clinical Cancer Research.2019;[Epub] CrossRef

The significance of chemokines in diffuse large B-cell lymphoma: a systematic review and future insights

The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro

Katrin Pansy, Julia Feichtinger, Barbara Ehall, Barbara Uhl, Miriam Sedej, David Roula, Beata Pursche, Axel Wolf, Manuel Zoidl, Elisabeth Steinbauer, Verena Gruber, Hildegard T Greinix, Katharina T. Prochazka, Gerhard G. Thallinger, Akos Heinemann, Christ

International Journal of Molecular Sciences.2019; 20(19): 4740. CrossRef

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients

Maria Bach Laursen, Linn Reinholdt, Anna Amanda Schönherz, Hanne Due, Ditte Starberg Jespersen, Lykke Grubach, Marianne Schmidt Ettrup, Rasmus Røge, Steffen Falgreen, Suzette Sørensen, Julie Støve Bødker, Alexander Schmitz, Hans E. Johnsen, Martin Bøgsted

C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges

Hui Du, Lei Gao, Jing Luan, Hangfan Zhang, Taiwu Xiao

Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma

Zi-Zhen Xu, Jian-Kang Shen, Shu-Qing Zhao, Jun-Min Li

The role of G protein-coupled receptors in lymphoid malignancies

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

Linn Reinholdt, Maria Bach Laursen, Alexander Schmitz, Julie Støve Bødker, Lasse Hjort Jakobsen, Martin Bøgsted, Hans Erik Johnsen, Karen Dybkær

Modeling the Pro-inflammatory Tumor Microenvironment in Acute Lymphoblastic Leukemia Predicts a Breakdown of Hematopoietic-Mesenchymal Communication Networks

Jennifer Enciso, Hector Mayani, Luis Mendoza, Rosana Pelayo

Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin

Susann Stollberg, Daniel Kämmerer, Elisa Neubauer, Stefan Schulz, Ingrid Simonitsch-Klupp, Barbara Kiesewetter, Markus Raderer, Amelie Lupp

Journal of Cancer Research and Clinical Oncology.2016; 142(11): 2239. CrossRef

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

Chi Young Ok, Zijun Y Xu-Monette, Ling Li, Ganiraju C Manyam, Santiago Montes-Moreno, Alexandar Tzankov, Carlo Visco, Karen Dybkær, Mark J Routbort, Li Zhang, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L Richards, Eric D Hsi, William W L C